A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment…

Overview of attention for article published in Trials, April 2014

Altmetric Badge

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 74 Mendeley
citeulike: 1 CiteULike

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 6 X users, with an upper bound of 8,525 followers.

ALICAT (anticoagulation length in cancer associated thrombosis) CI is @SimonNoble & you can read the study protocol: http://t.co/RgWMXoIDjO

Reply Repost Favourite

We are delighted that @BioMedCentral Trials have published the ALICAT study protocol http://t.co/RgWMXoIDjO

Reply Repost Favourite

We are delighted that @BioMedCentral Trials have published the ALICAT study protocol http://t.co/RgWMXoIDjO

Reply Repost Favourite

ALICAT (anticoagulation length in cancer associated thrombosis) CI is @SimonNoble & you can read the study protocol: http://t.co/RgWMXoIDjO

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.